Director, Process Chemistry

Vaga não está no LinkedIn

🕒 2 dias atrás

🇺🇸 Estados Unidos – Remoto (EUA)

💵 $210.000 - $230.000 / ano

⏰ Tempo Integral

🔴 Especialista

👔 Diretor

🦅 Patrocina Visto H1B

Esta empresa já patrocinou vistos H1B no passado.

Candidatar-se

Encontrar Vagas Remotas Similares

Configurar Alerta de Email para Novas Vagas

📊 Verifique sua pontuação de currículo para esta vaga

Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

Enviar Currículo

Praxis

SiteLinkedInTodas as Vagas

11 - 50 funcionários

Fundada em 2002

🏥 Saúde

💼 Consultoria

📦 Logística

Healthcare • Consulting • Logistics

A Praxis é uma empresa dedicada a conectar pacientes com oportunidades significativas de ensaios clínicos. Com foco na criação de programas de recrutamento personalizados, a Praxis utiliza uma variedade de ferramentas especializadas e vasta experiência em diversas áreas terapêuticas para garantir que alcancem os pacientes certos em todo o mundo. Estabelecida em 2002, a empresa enfatiza a importância do engajamento do paciente e utiliza insights sofisticados de dados para aprimorar a jornada do paciente na pesquisa clínica.

Descrição

• Lead drug substance activities for one or more small-molecule programs from clinical development through commercial readiness • Lead process chemistry research and development for projects from early to late phase • Design early-phase and late-phase/commercial drug substance processes and lead demonstration from laboratory to pilot plant • Provide chemistry and technical leadership throughout the product lifecycle • Lead or participate in identifying final API forms for pharmaceutical development • Collaborate with formulation, analytical, operations, engineering, and quality teams within the CMC organization • Identify, collaborate with, and lead external CRO and CDMO organizations to achieve deliverables • Analyze external experimental data to drive synthetic experimental plans at CROs and CDMOs • Author or co-author regulatory submissions • Define manufacturing strategy and execution, including GMP requirements and issue resolution • Assess and apply new trends and concerns in process development, quality, and manufacturing • Manage quarterly budgeting for drug-substance-related activities • Contribute to inventions that strengthen Praxis’ intellectual property position and add value for patients

🎯 Requisitos

• Advanced degree or commensurate equivalent experience in Chemistry, Pharmaceutical Sciences, Engineering, or a related discipline • Minimum 12 years of industry experience in CMC specifically for small-molecule drug substance • Strong knowledge of US and EU cGMP requirements and best practices for drug substances and drug products • Strong knowledge of CMC development across all phases, from initial regulatory filings through registration, validation, and launch • Experience working with third-party CRO/CMO partners and service providers to develop and manufacture pharmaceutical products • Scientific track record or working knowledge in continuous processing, biocatalysis, catalysis, and/or high-throughput experimentation is desirable • Experience with salt/crystalline form selection is preferred • Experience with oligonucleotide chemistry is a plus • High intellectual curiosity, innovation, creative problem solving, entrepreneurial spirit, and ability to thrive in an agile environment • Excellent interpersonal and communication skills, with ability to develop trusted relationships and encourage diversity • Highly organized and detail-oriented, with passion for delivering quality results • Flexibility and willingness to travel as needed

🏖️ Benefícios

• 99% of medical, dental and vision plan premiums paid • Company-paid life insurance • AD&D benefits • Disability benefits • Voluntary plans to personalize coverage • Dollar-for-dollar 401(k) matching up to 6% on eligible contributions • Long-term stock incentives • ESPP • Discretionary quarterly bonus • Flexible wellness benefit • Generous PTO • Paid holidays • Company-wide shutdowns